{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 470618776
| IUPAC_name = (''RS'')-2-(''tert''-butylamino)-1-(2-chlorophenyl)ethanol
| image = Tulobuterol.svg
| image2 = Tulobuterol ball-and-stick.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|tulobuterol}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = [[Inhaler|Inhaled]], oral

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 41570-61-0
| ATC_prefix = R03
| ATC_suffix = AC11
| ATC_supplemental =  
| PubChem = 5606
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5404
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 591I9SU0F7
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02151
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1159717

<!--Chemical data-->
| C=12 | H=18 | Cl=1 | N=1 | O=1 
| molecular_weight = 227.730 g/mol
| smiles = Clc1ccccc1C(O)CNC(C)(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H18ClNO/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13/h4-7,11,14-15H,8H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = YREYLAVBNPACJM-UHFFFAOYSA-N
}}
'''Tulobuterol''' ([[International Nonproprietary Name|INN]]) is a long-acting [[beta2-adrenergic receptor agonist]], marketed in Japan as a [[transdermal patch]] under the name '''Hokunalin tape''' (ホクナリンテープ).<ref>{{Cite journal 
| last1 = Horiguchi | first1 = T. 
| last2 = Kondo | first2 = R. 
| last3 = Miyazaki | first3 = J. 
| last4 = Fukumokto | first4 = K. 
| last5 = Torigoe | first5 = H. 
| title = Clinical Evaluation of a Transdermal Therapeutic System of the ß2-Agonist Tulobuterol in Patients with Mild or Moderate Persistent Bronchial Asthma 
| doi = 10.1055/s-0031-1296971 
| journal = Arzneimittelforschung 
| volume = 54 
| issue = 5 
| pages = 280–285 
| year = 2011 
| pmid = 15212190 
| pmc = 
}}</ref>

Currently, it is only legal in 7 countries: Japan, Germany, China, South Korea, Bangladesh, Pakistan, and Venezuela.

==References==
{{reflist}}

{{Adrenergic agonists}}
{{Asthma and copd rx}}

[[Category:Beta-adrenergic agonists]]
[[Category:Phenethylamines]]
[[Category:Chloroarenes]]


{{respiratory-system-drug-stub}}